98%
921
2 minutes
20
Psoriatic arthritis (PsA) is a systemic, immune-mediated disorder characterized by inflammation across peripheral and axial joints, entheses, skin, and nails. Given this heterogeneous manifestation, PsA presents unique challenges in clinical diagnosis and management. Conventional imaging, limited to localized, anatomical assessments, often fails to capture the full spectrum of PsA's systemic inflammatory burden, particularly subclinical disease. This review explores the emerging role of total-body positron emission tomography (TB-PET), offering a comprehensive assessment of molecular and metabolic processes across all affected tissues of the body in a single, short, low-dose scan. With PET radiotracers targeting glucose metabolism, T-cell trafficking, and macrophage activation, TB-PET may serve as a gateway to assess the spectrum and degree of inflammation in all the pathologic domains underlying PsA. Ultimately, by bridging molecular imaging with immunology and observable phenotypic features, TB-PET may open new avenues for understanding the pathophysiology of PsA, impacting both research paradigms and clinical strategies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12237434 | PMC |
http://dx.doi.org/10.1016/j.coi.2025.102587 | DOI Listing |
PET Clin
August 2025
Department of Integrative Oncology, BC Cancer Research Centre, Vancouver, Canada.
This article reviews recent advancements in PET/computed tomography imaging, emphasizing the transformative impact of total-body and long-axial field-of-view scanners, which offer increased sensitivity, larger coverage, and faster, lower-dose imaging. It highlights the growing role of artificial intelligence (AI) in enhancing image reconstruction, resolution, and multi-tracer applications, enabling rapid processing and improved quantification. AI-driven techniques, such as super-resolution, positron range correction, and motion compensation, are improving lesion detectability and image quality.
View Article and Find Full Text PDFPET Clin
August 2025
BioMedical Engineering and Imaging Institute, Icahn School of Medicine at Mount Sinai, Leon and Norma Hess Center for Science and Medicine, 1470 Madison Avenue 1st Floor, New York, NY 10029, USA. Electronic address:
Motion in clinical positron emission tomography (PET) examinations degrades image quality and quantification, requiring tailored correction strategies. Recent advancements integrate external devices and/or data-driven motion tracking with image registration and motion modeling, particularly deep learning-based methods, to address complex motion scenarios. The development of total-body PET systems with long axial field-of-view enables advanced motion correction by leveraging extended coverage and continuous acquisition.
View Article and Find Full Text PDFPhys Med Biol
September 2025
Research Center for Medical AI, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, People's Republic of China.
The lengthy 1 h dynamic positron emission tomography (PET) scans discomfort patients, add motion artifacts, and inflate costs, highlighting the need for tech advancements to reduce scan times. Therefore, we attempted to reconstruct multi-parametric imaging with only 20 min dynamic PET frames through deep learning techniques.Total-body PET data from 49 subjects (18 [Ga]Ga-FAPI-04 and 31 [Ga]Ga-prostate-specific membrane antigen (PSMA)-11) at Renji Hospital were used.
View Article and Find Full Text PDFBMC Med Imaging
August 2025
Nuclear Medicine Department, Beijing Friendship Hospital, Capital Medical University, 95 Yong'an Road, Xicheng District, Beijing, 100050, China.
Purpose: Congenital neuroblastoma represents a distinct subtype of neuroblastoma that originates during fetal and neonatal development. Limited research has been conducted on the prognostic significance of baseline Fluorine-18-Fluorodeoxyglucose positron emission tomography/computerized tomography (F-FDG PET/CT) in pediatric patients with congenital neuroblastoma. This study aims to characterize the baseline F-FDG PET/CT imaging features in children with congenital neuroblastoma.
View Article and Find Full Text PDFJ Nucl Med
September 2025
Department of Radiology, University of California Davis, Sacramento, California.
The improved sensitivity of total-body (TB) PET/CT offers the possibility of reducing injected activities. The aim of our study was to define a lower limit of reduced injected activities in [F]FDG TB PET/CT for interim and end-of-treatment assessment of patients with lymphoma at 2 acquisition times. Twenty-four consecutive patients with lymphoma who were undergoing interim and end-of-treatment TB PET/CT were prospectively enrolled in this study.
View Article and Find Full Text PDF